H
Hong-Lin Tan
Researcher at Amgen
Publications - 17
Citations - 17151
Hong-Lin Tan is an academic researcher from Amgen. The author has contributed to research in topics: Osteoclast & Osteoprotegerin. The author has an hindex of 15, co-authored 17 publications receiving 16503 citations. Previous affiliations of Hong-Lin Tan include Washington University in St. Louis & Jewish Hospital.
Papers
More filters
Journal ArticleDOI
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
David L. Lacey,Emma Timms,Hong-Lin Tan,Michael J. Kelley,Colin R. Dunstan,Tim Burgess,Robin Elliott,Anne Colombero,Gary Elliott,S. Scully,Hailing Hsu,John K. Sullivan,Nessa Hawkins,E. Davy,C. Capparelli,Alana Eli,Yi-xin Qian,Steve Kaufman,Ildiko Sarosi,Victoria Shalhoub,Giorgio Senaldi,Jane Guo,John M. Delaney,William J. Boyle +23 more
TL;DR: The effects of OPGL are blocked in vitro and in vivo by OPG, suggesting that OPGl and OPG are key extracellular regulators of osteoclast development.
Journal ArticleDOI
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
William S. Simonet,David L. Lacey,Colin R. Dunstan,Michael J. Kelley,Ming-Shi Chang,R Lüthy,Hung Q. Nguyen,S Wooden,L Bennett,Tom Boone,Grant Shimamoto,Margaret L. DeRose,Robin Elliott,Anne Colombero,Hong-Lin Tan,Geraldine Trail,John K. Sullivan,E. Davy,N. Bucay,L Renshaw-Gegg,T.M Hughes,Dave Hill,W Pattison,Patricia Shehan Campbell,S Sander,Gwyneth Van,John E. Tarpley,P Derby,Richard Lee,William J. Boyle +29 more
TL;DR: Data show that OPG can act as a soluble factor in the regulation of bone mass and imply a utility for OPG in the treatment of osteoporosis associated with increased osteoclast activity.
Journal ArticleDOI
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Young-Yun Kong,Hiroki Yoshida,Ildiko Sarosi,Hong-Lin Tan,Emma Timms,Casey Capparelli,Sean Morony,Antonio J. Oliveira-dos-Santos,Gwyneth Van,Annick Itie,Wilson Khoo,Andrew Wakeham,Colin R. Dunstan,David L. Lacey,Tak W. Mak,William J. Boyle,Josef M. Penninger +16 more
TL;DR: OPGL is a new regulator of lymph-node organogenesis and lymphocyte development and is an essential osteoclast differentiation factor in vivo.
Journal ArticleDOI
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
Hailing Hsu,David L. Lacey,Colin R. Dunstan,Irina Solovyev,Anne Colombero,Emma Timms,Hong-Lin Tan,Gary Elliott,Michael J. Kelley,Ildiko Sarosi,Ling Wang,Xing-Zhong Xia,Robin Elliott,Laura Chiu,Tabitha Black,Sheila Scully,Casey Capparelli,Sean Morony,Grant Shimamoto,Michael Bass,William J. Boyle +20 more
TL;DR: Data indicate that OPGL-induced osteoclastogenesis is directly mediated through RANK on osteocLast precursor cells, and polyclonal Ab against the RANK extracellular domain promotes osteoclineogenesis in bone marrow cultures suggesting that RANK activation mediates the effects of OPGl on the osteoc last pathway.
Journal ArticleDOI
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
Ji Li,Ildiko Sarosi,Xiao-Qiang Yan,Sean Morony,Casey Capparelli,Hong-Lin Tan,Susan McCabe,Robin Elliott,Sheila Scully,Gwyneth Van,Stephen J. Kaufman,Shao-Chieh Juan,Yu Sun,John E. Tarpley,Laura Martín,Kathleen Christensen,James McCabe,Paul J. Kostenuik,Hailing Hsu,Frederick A. Fletcher,Colin R. Dunstan,David L. Lacey,William J. Boyle +22 more
TL;DR: Data indicate that RANK is the intrinsic cell surface determinant that mediates osteoprotegerin ligand effects on bone resorption and remodeling as well as the physiological and pathological effects of calciotropic hormones and proresorptive cytokines.